Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 Sep;33(9):1153–1154. doi: 10.1136/gut.33.9.1153

Chemotherapy for gastric cancer.

A Saini 1, J Waxman 1
PMCID: PMC1379475  PMID: 1427363

Full text

PDF
1153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cadman E., Heimer R., Davis L. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. Science. 1979 Sep 14;205(4411):1135–1137. doi: 10.1126/science.472732. [DOI] [PubMed] [Google Scholar]
  2. Cullinan S. A., Moertel C. G., Fleming T. R., Rubin J. R., Krook J. E., Everson L. K., Windschitl H. E., Twito D. I., Marschke R. F., Foley J. F. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. JAMA. 1985 Apr 12;253(14):2061–2067. [PubMed] [Google Scholar]
  3. Douglass H. O., Jr, Lavin P. T., Goudsmit A., Klaassen D. J., Paul A. R. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). J Clin Oncol. 1984 Dec;2(12):1372–1381. doi: 10.1200/JCO.1984.2.12.1372. [DOI] [PubMed] [Google Scholar]
  4. MacDonald J. S., Schein P. S., Woolley P. V., Smythe T., Ueno W., Hoth D., Smith F., Boiron M., Gisselbrecht C., Brunet R. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med. 1980 Oct;93(4):533–536. doi: 10.7326/0003-4819-93-4-533. [DOI] [PubMed] [Google Scholar]
  5. Macdonald J. S., Gohmann J. J. Chemotherapy of advanced gastric cancer: present status, future prospects. Semin Oncol. 1988 Jun;15(3 Suppl 4):42–49. [PubMed] [Google Scholar]
  6. Moertel C. G., Rubin J., O'Connell M. J., Schutt A. J., Wieand H. S. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol. 1986 Jul;4(7):1053–1057. doi: 10.1200/JCO.1986.4.7.1053. [DOI] [PubMed] [Google Scholar]
  7. Wilke H., Preusser P., Fink U., Achterrath W., Meyer H. J., Stahl M., Lenaz L., Meyer J., Siewert J. R., Geerlings H. New developments in the treatment of gastric carcinoma. Semin Oncol. 1990 Feb;17(1 Suppl 2):61–70. [PubMed] [Google Scholar]
  8. Wilke H., Preusser P., Fink U., Gunzer U., Meyer H. J., Meyer J., Siewert J. R., Achterrath W., Lenaz L., Knipp H. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol. 1989 Sep;7(9):1318–1326. doi: 10.1200/JCO.1989.7.9.1318. [DOI] [PubMed] [Google Scholar]
  9. Wils J. A., Klein H. O., Wagener D. J., Bleiberg H., Reis H., Korsten F., Conroy T., Fickers M., Leyvraz S., Buyse M. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol. 1991 May;9(5):827–831. doi: 10.1200/JCO.1991.9.5.827. [DOI] [PubMed] [Google Scholar]
  10. Wils J., Bleiberg H., Dalesio O., Blijham G., Mulder N., Planting A., Splinter T., Duez N. An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer. J Clin Oncol. 1986 Dec;4(12):1799–1803. doi: 10.1200/JCO.1986.4.12.1799. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES